Arcutis Biotherapeutics

ARQT

28.2602.65% ( +0.730 )

Closed: Nov 13, 16:00:00 (EDT)

Current ValuationThe current P/E ratio is 119.48, above the reasonable range, cheaper than 6.9% of the time in the past 1 years, and the industry ranks 67/607, the industry Median -1.72.

119.48xP/E

Stock price$28.26Earnings per share$0.24

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

0306090120

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
BIIBUSBiogen	107.79x	43.65%	$37.46B
ARQTUSArcutis Biotherapeutics	119.48x	297.44%	$3.57B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.